{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:39:05Z","timestamp":1790753945304,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.vaccine.2005.03.028","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T11:41:32Z","timestamp":1114602092000},"page":"4029-4035","source":"Crossref","is-referenced-by-count":12,"title":["Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant"],"prefix":"10.1016","volume":"23","author":[{"given":"Roberto A.","family":"DePaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth J.","family":"Advant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.03.028_bib1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/(SICI)1097-4598(199806)21:6<701::AID-MUS1>3.0.CO;2-B","article-title":"Clinical spectrum of botulism","volume":"21","author":"Cherington","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.vaccine.2005.03.028_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2958.1994.tb00396.x","article-title":"Mechanism of action of tetanus and botulinum neurotoxins","volume":"13","author":"Montecucco","year":"1994","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2005.03.028_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1348-0421.1995.tb02184.x","article-title":"Structure and function of Clostridium botulinum toxins","volume":"39","author":"Oguma","year":"1995","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2005.03.028_bib4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0968-0004(02)02177-1","article-title":"Botulinum and tetanus neurotoxins: structure, function and therapeutic utility","volume":"27","author":"Turton","year":"2002","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.vaccine.2005.03.028_bib5","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1128\/IAI.66.10.4817-4822.1998","article-title":"Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate","volume":"66","author":"Byrne","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.03.028_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1006\/prep.1998.0910","article-title":"Production and purification of the heavy-chain fragment C of botulinum neurotoxin, serotype B, expressed in the methylotrophic yeast Pichia pastoris","volume":"13","author":"Potter","year":"1998","journal-title":"Protein Express Purif"},{"key":"10.1016\/j.vaccine.2005.03.028_bib7","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0041-0101(98)00146-9","article-title":"Development of recombinant vaccines for botulinum neurotoxin","volume":"36","author":"Smith","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2005.03.028_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1006\/prep.2000.1256","article-title":"Production and purification of the heavy chain fragment C of botulinum neurotoxin, serotype A, expressed in the methylotrophic yeast Pichia pastoris","volume":"19","author":"Potter","year":"2000","journal-title":"Protein Express Purif"},{"key":"10.1016\/j.vaccine.2005.03.028_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0168-1656(02)00182-7","article-title":"Recovery of intracellular recombinant proteins from the yeast Pichia pastoris by cell permeabilization","volume":"99","author":"Shepard","year":"2002","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2005.03.028_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0021-9673(02)00074-2","article-title":"Initial purification of recombinant botulinum neurotoxin fragments for pharmaceutical production using hydrophobic charge induction chromatography","volume":"952","author":"Weatherly","year":"2002","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.vaccine.2005.03.028_bib11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0300-9084(00)01173-1","article-title":"Development of vaccines for prevention of botulism","volume":"82","author":"Byrne","year":"2000","journal-title":"Biochimie"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2005.03.028_bib12","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0264-410X(02)00163-9","article-title":"Workshop summary. Aluminum in vaccines","volume":"20","author":"Eickhoff","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.03.028_bib13","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1023\/A:1016266916893","article-title":"Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum","volume":"12","author":"Weissburg","year":"1995","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2005.03.028_bib14","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0264-410X(96)00073-4","article-title":"In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid","volume":"14","author":"Gupta","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.03.028_bib15","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1016\/S0264-410X(00)00559-4","article-title":"Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits","volume":"19","author":"Chang","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.03.028_bib16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0264-410X(01)00313-9","article-title":"Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines","volume":"20","author":"Shi","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.03.028_bib17","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0264-410X(02)00556-X","article-title":"Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production","volume":"21","author":"Iyer","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.03.028_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0264-410X(01)00317-6","article-title":"The role of the adsorption process for production and control combined adsorbed vaccines","volume":"20","author":"Matheis","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.03.028_bib19","series-title":"Physico-Chemical Procedures for the Characterization of Vaccines","first-page":"217","article-title":"Characterization of aluminium-containing adjuvants","author":"White","year":"2000"},{"key":"10.1016\/j.vaccine.2005.03.028_bib20","first-page":"25","article-title":"Role of the electrostatic attractive force in the adsorption of proteins by aluminum hydroxide adjuvant","volume":"51","author":"Chang","year":"1997","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1016\/j.vaccine.2005.03.028_bib21","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1023\/A:1015843210358","article-title":"The importance of surface charge in the optimization of antigen-adjuvant interactions","volume":"8","author":"Callahan","year":"1991","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2005.03.028_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0264-410X(95)80009-3","article-title":"Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-containing adjuvants","volume":"13","author":"Al-Shakhshir","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.03.028_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0166-6622(92)80122-I","article-title":"Adsorption, desorption and re-adsorption of proteins on solid surfaces","volume":"66","author":"Norde","year":"1992","journal-title":"Colloids Surf"},{"key":"10.1016\/j.vaccine.2005.03.028_bib24","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1023\/B:PHAM.0000036908.70139.f1","article-title":"Use of biophysical characterization in preformulation development of a heavy-chain fragment of botulinum serotype B: evaluation of suitable purification process conditions","volume":"21","author":"Bedu-Addo","year":"2004","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2005.03.028_bib25","article-title":"Biophysical characterization and preformulation vaccine development of a C-terminal heavy chain fragment derived from botulinum neurotoxin serotype A","volume":"4","author":"Acharya","year":"2002","journal-title":"AAPS Pharm Sci"},{"key":"10.1016\/j.vaccine.2005.03.028_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/prot.340190207","article-title":"Accuracy of protein flexibility predictions","volume":"19","author":"Vihinen","year":"1994","journal-title":"Proteins"},{"key":"10.1016\/j.vaccine.2005.03.028_bib27","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1016\/S0264-410X(01)00168-2","article-title":"A novel bipolar mode of attachment to aluminium-containing adjuvants by BBG2Na, a recombinant subunit hRSV vaccine","volume":"19","author":"Dagouassat","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.03.028_bib28","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/jps.2600731104","article-title":"Adsorption of pepsin by aluminum hydroxide I: adsorption mechanism","volume":"73","author":"Sepelyak","year":"1984","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2005.03.028_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1081\/PDT-120017526","article-title":"Effect of the degree of phosphate substitution in aluminum hydroxide adjuvant on the adsorption of phosphorylated proteins","volume":"8","author":"Iyer","year":"2003","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.vaccine.2005.03.028_bib30","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0264-410X(94)90127-9","article-title":"Effect of protein adsorption on the surface charge characteristics of aluminium-containing adjuvants","volume":"12","author":"Al-Shakhshir","year":"1994","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05003798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05003798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T02:45:39Z","timestamp":1586227539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05003798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":30,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0264410X05003798"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.03.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}